Bayer Drug Iberogast Under Investigation

Bayer AG’s (BAYN.XE) digestive medication Iberogast is at the center of an investigation by the Cologne public prosecutor’s office for a possible connection with the death of a person who took the medication, German business magazine Handelsblatt reports.

–According to the publication, the conglomerate refused to add warnings about possible liver damage and failure to the drug’s package leaflet for years.

–The company only added them last year, when it became known that a woman in Germany died of liver failure and interior bleeding who previously took the medication, Handelsblatt reports.

–Bayer wasn’t immediately available for comment.

Full story (in German): https://bit.ly/2Y9Sncd

https://www.marketscreener.com/BAYER-AG-436063/news/Bayer-Drug-Iberogast-Under-Investigation-Handelsblatt-28938150/?countview=0